nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefadroxil—SLC22A5—Crohn's disease	0.768	1	CbGaD
Cefadroxil—SLC22A8—Mercaptopurine—Crohn's disease	0.129	1	CbGbCtD
Cefadroxil—Infertility—Mesalazine—Crohn's disease	0.00435	0.062	CcSEcCtD
Cefadroxil—SLC22A5—Organic cation transport—SLC22A4—Crohn's disease	0.00419	0.161	CbGpPWpGaD
Cefadroxil—SLC22A5—Organic cation/anion/zwitterion transport—SLC22A4—Crohn's disease	0.00284	0.109	CbGpPWpGaD
Cefadroxil—Cholestasis—Mercaptopurine—Crohn's disease	0.00275	0.0393	CcSEcCtD
Cefadroxil—Pruritus genital—Mesalazine—Crohn's disease	0.00272	0.0387	CcSEcCtD
Cefadroxil—SLC22A8—Organic cation/anion/zwitterion transport—SLC22A5—Crohn's disease	0.00257	0.0985	CbGpPWpGaD
Cefadroxil—SLC22A8—Organic cation/anion/zwitterion transport—SLC22A4—Crohn's disease	0.00257	0.0985	CbGpPWpGaD
Cefadroxil—Lactic dehydrogenase activity increased—Mesalazine—Crohn's disease	0.00222	0.0316	CcSEcCtD
Cefadroxil—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A4—Crohn's disease	0.00215	0.0822	CbGpPWpGaD
Cefadroxil—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A5—Crohn's disease	0.00215	0.0822	CbGpPWpGaD
Cefadroxil—Nephropathy toxic—Mesalazine—Crohn's disease	0.00198	0.0282	CcSEcCtD
Cefadroxil—Blood lactate dehydrogenase increased—Mesalazine—Crohn's disease	0.00195	0.0278	CcSEcCtD
Cefadroxil—Cholestasis—Azathioprine—Crohn's disease	0.00164	0.0234	CcSEcCtD
Cefadroxil—Cholestasis—Mesalazine—Crohn's disease	0.0015	0.0213	CcSEcCtD
Cefadroxil—Pancytopenia—Mercaptopurine—Crohn's disease	0.00125	0.0178	CcSEcCtD
Cefadroxil—Blood bilirubin increased—Mesalazine—Crohn's disease	0.0012	0.0171	CcSEcCtD
Cefadroxil—Aplastic anaemia—Azathioprine—Crohn's disease	0.00117	0.0167	CcSEcCtD
Cefadroxil—Phosphatase alkaline increased—Mesalazine—Crohn's disease	0.00114	0.0162	CcSEcCtD
Cefadroxil—Vaginal inflammation—Mesalazine—Crohn's disease	0.00114	0.0162	CcSEcCtD
Cefadroxil—Vaginal infection—Mesalazine—Crohn's disease	0.00107	0.0153	CcSEcCtD
Cefadroxil—Blood urea increased—Mesalazine—Crohn's disease	0.00107	0.0153	CcSEcCtD
Cefadroxil—Aplastic anaemia—Mesalazine—Crohn's disease	0.00107	0.0152	CcSEcCtD
Cefadroxil—Hepatic function abnormal—Azathioprine—Crohn's disease	0.00104	0.0148	CcSEcCtD
Cefadroxil—Hepatic failure—Azathioprine—Crohn's disease	0.00101	0.0144	CcSEcCtD
Cefadroxil—Blood alkaline phosphatase increased—Mesalazine—Crohn's disease	0.000948	0.0135	CcSEcCtD
Cefadroxil—Cephaloglycin—SLC22A5—Crohn's disease	0.000941	0.141	CrCbGaD
Cefadroxil—Hepatic failure—Mesalazine—Crohn's disease	0.000917	0.0131	CcSEcCtD
Cefadroxil—Toxic epidermal necrolysis—Azathioprine—Crohn's disease	0.000815	0.0116	CcSEcCtD
Cefadroxil—Arthralgia—Mercaptopurine—Crohn's disease	0.000779	0.0111	CcSEcCtD
Cefadroxil—Blood creatinine increased—Mesalazine—Crohn's disease	0.000772	0.011	CcSEcCtD
Cefadroxil—Pancytopenia—Azathioprine—Crohn's disease	0.000743	0.0106	CcSEcCtD
Cefadroxil—Cramp muscle—Mesalazine—Crohn's disease	0.000742	0.0106	CcSEcCtD
Cefadroxil—Aspartate aminotransferase increased—Mesalazine—Crohn's disease	0.000742	0.0106	CcSEcCtD
Cefadroxil—Thrombocytopenia—Mercaptopurine—Crohn's disease	0.000731	0.0104	CcSEcCtD
Cefadroxil—Alanine aminotransferase increased—Mesalazine—Crohn's disease	0.000727	0.0104	CcSEcCtD
Cefadroxil—Eosinophilia—Mesalazine—Crohn's disease	0.000705	0.0101	CcSEcCtD
Cefadroxil—Cefixime—SLC22A5—Crohn's disease	0.000697	0.104	CrCbGaD
Cefadroxil—Stevens-Johnson syndrome—Azathioprine—Crohn's disease	0.000691	0.00985	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.00068	0.00969	CcSEcCtD
Cefadroxil—Pancytopenia—Mesalazine—Crohn's disease	0.000676	0.00964	CcSEcCtD
Cefadroxil—Neutropenia—Mesalazine—Crohn's disease	0.000666	0.00949	CcSEcCtD
Cefadroxil—Agranulocytosis—Azathioprine—Crohn's disease	0.000651	0.00927	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.000644	0.00918	CcSEcCtD
Cefadroxil—Cefdinir—SLC22A5—Crohn's disease	0.000643	0.0964	CrCbGaD
Cefadroxil—Stevens-Johnson syndrome—Mesalazine—Crohn's disease	0.00063	0.00897	CcSEcCtD
Cefadroxil—Haemoglobin—Azathioprine—Crohn's disease	0.000629	0.00897	CcSEcCtD
Cefadroxil—Haemorrhage—Azathioprine—Crohn's disease	0.000626	0.00892	CcSEcCtD
Cefadroxil—Cefradine—SLC22A5—Crohn's disease	0.000611	0.0916	CrCbGaD
Cefadroxil—Agranulocytosis—Mesalazine—Crohn's disease	0.000593	0.00845	CcSEcCtD
Cefadroxil—Erythema multiforme—Azathioprine—Crohn's disease	0.000592	0.00844	CcSEcCtD
Cefadroxil—Body temperature increased—Mercaptopurine—Crohn's disease	0.00059	0.00841	CcSEcCtD
Cefadroxil—Haemoglobin—Mesalazine—Crohn's disease	0.000573	0.00817	CcSEcCtD
Cefadroxil—Haemorrhage—Mesalazine—Crohn's disease	0.00057	0.00813	CcSEcCtD
Cefadroxil—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A4—Crohn's disease	0.00057	0.0218	CbGpPWpGaD
Cefadroxil—Hypersensitivity—Mercaptopurine—Crohn's disease	0.00055	0.00784	CcSEcCtD
Cefadroxil—Ampicillin—SLC22A5—Crohn's disease	0.000542	0.0812	CrCbGaD
Cefadroxil—Erythema multiforme—Mesalazine—Crohn's disease	0.000539	0.00768	CcSEcCtD
Cefadroxil—Cefdinir—MPO—Crohn's disease	0.000534	0.08	CrCbGaD
Cefadroxil—Cefaclor—MPO—Crohn's disease	0.000529	0.0793	CrCbGaD
Cefadroxil—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—Crohn's disease	0.000515	0.0197	CbGpPWpGaD
Cefadroxil—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A4—Crohn's disease	0.000515	0.0197	CbGpPWpGaD
Cefadroxil—Diarrhoea—Mercaptopurine—Crohn's disease	0.000511	0.00728	CcSEcCtD
Cefadroxil—Tension—Mesalazine—Crohn's disease	0.000487	0.00694	CcSEcCtD
Cefadroxil—Nervousness—Mesalazine—Crohn's disease	0.000482	0.00687	CcSEcCtD
Cefadroxil—Muscle spasms—Mesalazine—Crohn's disease	0.000477	0.0068	CcSEcCtD
Cefadroxil—Vomiting—Mercaptopurine—Crohn's disease	0.000475	0.00676	CcSEcCtD
Cefadroxil—Rash—Mercaptopurine—Crohn's disease	0.000471	0.00671	CcSEcCtD
Cefadroxil—Dermatitis—Mercaptopurine—Crohn's disease	0.00047	0.0067	CcSEcCtD
Cefadroxil—Arthralgia—Azathioprine—Crohn's disease	0.000464	0.00661	CcSEcCtD
Cefadroxil—Angioedema—Mesalazine—Crohn's disease	0.000454	0.00646	CcSEcCtD
Cefadroxil—Vertigo—Mesalazine—Crohn's disease	0.000446	0.00636	CcSEcCtD
Cefadroxil—Nausea—Mercaptopurine—Crohn's disease	0.000443	0.00632	CcSEcCtD
Cefadroxil—Thrombocytopenia—Azathioprine—Crohn's disease	0.000435	0.00621	CcSEcCtD
Cefadroxil—Cefalotin—SLC22A5—Crohn's disease	0.000435	0.0652	CrCbGaD
Cefadroxil—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—Crohn's disease	0.00043	0.0165	CbGpPWpGaD
Cefadroxil—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A4—Crohn's disease	0.00043	0.0165	CbGpPWpGaD
Cefadroxil—Arthralgia—Mesalazine—Crohn's disease	0.000423	0.00602	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.000405	0.00577	CcSEcCtD
Cefadroxil—Anaphylactic shock—Mesalazine—Crohn's disease	0.000405	0.00577	CcSEcCtD
Cefadroxil—Thrombocytopenia—Mesalazine—Crohn's disease	0.000397	0.00565	CcSEcCtD
Cefadroxil—Cephalexin—SLC22A5—Crohn's disease	0.000395	0.0592	CrCbGaD
Cefadroxil—Alanine aminotransferase increased—Prednisone—Crohn's disease	0.000385	0.00548	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.000384	0.00547	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.000369	0.00526	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Azathioprine—Crohn's disease	0.000364	0.00518	CcSEcCtD
Cefadroxil—Somnolence—Mesalazine—Crohn's disease	0.00036	0.00513	CcSEcCtD
Cefadroxil—Dyspepsia—Mesalazine—Crohn's disease	0.000357	0.00508	CcSEcCtD
Cefadroxil—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—Crohn's disease	0.000355	0.0136	CbGpPWpGaD
Cefadroxil—Neutropenia—Prednisone—Crohn's disease	0.000352	0.00502	CcSEcCtD
Cefadroxil—Abdominal pain—Azathioprine—Crohn's disease	0.000352	0.00501	CcSEcCtD
Cefadroxil—Body temperature increased—Azathioprine—Crohn's disease	0.000352	0.00501	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.00035	0.00498	CcSEcCtD
Cefadroxil—Cefpiramide—ALB—Crohn's disease	0.000344	0.0516	CrCbGaD
Cefadroxil—Gastrointestinal pain—Mesalazine—Crohn's disease	0.000331	0.00472	CcSEcCtD
Cefadroxil—Hypersensitivity—Azathioprine—Crohn's disease	0.000328	0.00467	CcSEcCtD
Cefadroxil—Urticaria—Mesalazine—Crohn's disease	0.000322	0.00459	CcSEcCtD
Cefadroxil—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—Crohn's disease	0.000321	0.0123	CbGpPWpGaD
Cefadroxil—Abdominal pain—Mesalazine—Crohn's disease	0.00032	0.00456	CcSEcCtD
Cefadroxil—Body temperature increased—Mesalazine—Crohn's disease	0.00032	0.00456	CcSEcCtD
Cefadroxil—Diarrhoea—Azathioprine—Crohn's disease	0.000304	0.00434	CcSEcCtD
Cefadroxil—Haemoglobin—Prednisone—Crohn's disease	0.000303	0.00432	CcSEcCtD
Cefadroxil—Haemorrhage—Prednisone—Crohn's disease	0.000302	0.0043	CcSEcCtD
Cefadroxil—Cefonicid—ALB—Crohn's disease	0.0003	0.0449	CrCbGaD
Cefadroxil—Hypersensitivity—Mesalazine—Crohn's disease	0.000298	0.00425	CcSEcCtD
Cefadroxil—Dizziness—Azathioprine—Crohn's disease	0.000294	0.00419	CcSEcCtD
Cefadroxil—Asthenia—Mesalazine—Crohn's disease	0.000291	0.00414	CcSEcCtD
Cefadroxil—Pruritus—Mesalazine—Crohn's disease	0.000287	0.00408	CcSEcCtD
Cefadroxil—SLC15A2—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	0.000284	0.0109	CbGpPWpGaD
Cefadroxil—SLC15A2—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	0.000284	0.0109	CbGpPWpGaD
Cefadroxil—Vomiting—Azathioprine—Crohn's disease	0.000283	0.00403	CcSEcCtD
Cefadroxil—Rash—Azathioprine—Crohn's disease	0.00028	0.004	CcSEcCtD
Cefadroxil—Dermatitis—Azathioprine—Crohn's disease	0.00028	0.00399	CcSEcCtD
Cefadroxil—Headache—Azathioprine—Crohn's disease	0.000279	0.00397	CcSEcCtD
Cefadroxil—Diarrhoea—Mesalazine—Crohn's disease	0.000277	0.00395	CcSEcCtD
Cefadroxil—Dizziness—Mesalazine—Crohn's disease	0.000268	0.00382	CcSEcCtD
Cefadroxil—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—Crohn's disease	0.000268	0.0103	CbGpPWpGaD
Cefadroxil—Nausea—Azathioprine—Crohn's disease	0.000264	0.00376	CcSEcCtD
Cefadroxil—SLC15A1—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	0.000263	0.0101	CbGpPWpGaD
Cefadroxil—SLC15A1—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	0.000263	0.0101	CbGpPWpGaD
Cefadroxil—SLC22A5—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	0.000259	0.00992	CbGpPWpGaD
Cefadroxil—Vomiting—Mesalazine—Crohn's disease	0.000258	0.00367	CcSEcCtD
Cefadroxil—Rash—Mesalazine—Crohn's disease	0.000255	0.00364	CcSEcCtD
Cefadroxil—Dermatitis—Mesalazine—Crohn's disease	0.000255	0.00364	CcSEcCtD
Cefadroxil—Headache—Mesalazine—Crohn's disease	0.000254	0.00362	CcSEcCtD
Cefadroxil—Nausea—Mesalazine—Crohn's disease	0.000241	0.00343	CcSEcCtD
Cefadroxil—Angioedema—Prednisone—Crohn's disease	0.00024	0.00342	CcSEcCtD
Cefadroxil—Vertigo—Prednisone—Crohn's disease	0.000236	0.00336	CcSEcCtD
Cefadroxil—SLC22A8—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	0.000234	0.00897	CbGpPWpGaD
Cefadroxil—SLC22A8—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	0.000234	0.00897	CbGpPWpGaD
Cefadroxil—Convulsion—Prednisone—Crohn's disease	0.000228	0.00324	CcSEcCtD
Cefadroxil—Arthralgia—Prednisone—Crohn's disease	0.000224	0.00319	CcSEcCtD
Cefadroxil—Anaphylactic shock—Prednisone—Crohn's disease	0.000214	0.00305	CcSEcCtD
Cefadroxil—SLC15A2—SLC-mediated transmembrane transport—GCKR—Crohn's disease	0.0002	0.00766	CbGpPWpGaD
Cefadroxil—SLC22A6—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	0.000195	0.00749	CbGpPWpGaD
Cefadroxil—SLC22A6—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	0.000195	0.00749	CbGpPWpGaD
Cefadroxil—Musculoskeletal discomfort—Prednisone—Crohn's disease	0.000195	0.00278	CcSEcCtD
Cefadroxil—Dyspepsia—Prednisone—Crohn's disease	0.000189	0.00269	CcSEcCtD
Cefadroxil—SLC15A1—SLC-mediated transmembrane transport—GCKR—Crohn's disease	0.000185	0.0071	CbGpPWpGaD
Cefadroxil—SLC22A5—SLC-mediated transmembrane transport—GCKR—Crohn's disease	0.000182	0.00699	CbGpPWpGaD
Cefadroxil—Cefoperazone—ALB—Crohn's disease	0.000177	0.0265	CrCbGaD
Cefadroxil—SLC15A2—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	0.000177	0.00677	CbGpPWpGaD
Cefadroxil—Gastrointestinal pain—Prednisone—Crohn's disease	0.000175	0.0025	CcSEcCtD
Cefadroxil—Urticaria—Prednisone—Crohn's disease	0.00017	0.00243	CcSEcCtD
Cefadroxil—Abdominal pain—Prednisone—Crohn's disease	0.000169	0.00241	CcSEcCtD
Cefadroxil—Body temperature increased—Prednisone—Crohn's disease	0.000169	0.00241	CcSEcCtD
Cefadroxil—SLC22A8—SLC-mediated transmembrane transport—GCKR—Crohn's disease	0.000165	0.00632	CbGpPWpGaD
Cefadroxil—SLC15A1—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	0.000164	0.00628	CbGpPWpGaD
Cefadroxil—SLC22A5—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	0.000161	0.00618	CbGpPWpGaD
Cefadroxil—Hypersensitivity—Prednisone—Crohn's disease	0.000158	0.00225	CcSEcCtD
Cefadroxil—Asthenia—Prednisone—Crohn's disease	0.000154	0.00219	CcSEcCtD
Cefadroxil—Pruritus—Prednisone—Crohn's disease	0.000152	0.00216	CcSEcCtD
Cefadroxil—Ampicillin—ALB—Crohn's disease	0.00015	0.0225	CrCbGaD
Cefadroxil—Diarrhoea—Prednisone—Crohn's disease	0.000147	0.00209	CcSEcCtD
Cefadroxil—SLC22A8—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	0.000146	0.00559	CbGpPWpGaD
Cefadroxil—Cefazolin—ALB—Crohn's disease	0.000145	0.0218	CrCbGaD
Cefadroxil—SLC15A2—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000144	0.00552	CbGpPWpGaD
Cefadroxil—SLC15A2—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000144	0.00552	CbGpPWpGaD
Cefadroxil—Dizziness—Prednisone—Crohn's disease	0.000142	0.00202	CcSEcCtD
Cefadroxil—SLC22A6—SLC-mediated transmembrane transport—GCKR—Crohn's disease	0.000138	0.00527	CbGpPWpGaD
Cefadroxil—Vomiting—Prednisone—Crohn's disease	0.000136	0.00194	CcSEcCtD
Cefadroxil—Rash—Prednisone—Crohn's disease	0.000135	0.00193	CcSEcCtD
Cefadroxil—Dermatitis—Prednisone—Crohn's disease	0.000135	0.00192	CcSEcCtD
Cefadroxil—Headache—Prednisone—Crohn's disease	0.000134	0.00191	CcSEcCtD
Cefadroxil—SLC15A1—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000134	0.00512	CbGpPWpGaD
Cefadroxil—SLC15A1—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000134	0.00512	CbGpPWpGaD
Cefadroxil—SLC22A5—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000132	0.00504	CbGpPWpGaD
Cefadroxil—Nausea—Prednisone—Crohn's disease	0.000127	0.00181	CcSEcCtD
Cefadroxil—SLC22A6—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	0.000122	0.00466	CbGpPWpGaD
Cefadroxil—Cefalotin—ALB—Crohn's disease	0.000121	0.0181	CrCbGaD
Cefadroxil—SLC22A8—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000119	0.00456	CbGpPWpGaD
Cefadroxil—SLC22A8—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000119	0.00456	CbGpPWpGaD
Cefadroxil—Cephalexin—ALB—Crohn's disease	0.00011	0.0164	CrCbGaD
Cefadroxil—SLC15A2—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.000102	0.00389	CbGpPWpGaD
Cefadroxil—SLC22A6—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	9.93e-05	0.0038	CbGpPWpGaD
Cefadroxil—SLC22A6—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	9.93e-05	0.0038	CbGpPWpGaD
Cefadroxil—SLC15A1—Transmembrane transport of small molecules—GCKR—Crohn's disease	9.43e-05	0.00361	CbGpPWpGaD
Cefadroxil—SLC22A5—Transmembrane transport of small molecules—GCKR—Crohn's disease	9.27e-05	0.00355	CbGpPWpGaD
Cefadroxil—SLC15A2—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	8.98e-05	0.00344	CbGpPWpGaD
Cefadroxil—SLC22A8—Transmembrane transport of small molecules—GCKR—Crohn's disease	8.38e-05	0.00321	CbGpPWpGaD
Cefadroxil—SLC15A1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	8.33e-05	0.00319	CbGpPWpGaD
Cefadroxil—SLC22A5—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	8.19e-05	0.00314	CbGpPWpGaD
Cefadroxil—SLC22A8—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	7.41e-05	0.00284	CbGpPWpGaD
Cefadroxil—SLC22A6—Transmembrane transport of small molecules—GCKR—Crohn's disease	7e-05	0.00268	CbGpPWpGaD
Cefadroxil—SLC15A2—SLC-mediated transmembrane transport—ALB—Crohn's disease	6.36e-05	0.00244	CbGpPWpGaD
Cefadroxil—SLC22A6—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	6.19e-05	0.00237	CbGpPWpGaD
Cefadroxil—SLC15A1—SLC-mediated transmembrane transport—ALB—Crohn's disease	5.9e-05	0.00226	CbGpPWpGaD
Cefadroxil—SLC22A5—SLC-mediated transmembrane transport—ALB—Crohn's disease	5.81e-05	0.00222	CbGpPWpGaD
Cefadroxil—SLC22A8—SLC-mediated transmembrane transport—ALB—Crohn's disease	5.25e-05	0.00201	CbGpPWpGaD
Cefadroxil—SLC22A6—SLC-mediated transmembrane transport—ALB—Crohn's disease	4.38e-05	0.00168	CbGpPWpGaD
Cefadroxil—SLC15A2—Transmembrane transport of small molecules—ALB—Crohn's disease	3.23e-05	0.00124	CbGpPWpGaD
Cefadroxil—SLC15A1—Transmembrane transport of small molecules—ALB—Crohn's disease	3e-05	0.00115	CbGpPWpGaD
Cefadroxil—SLC22A5—Transmembrane transport of small molecules—ALB—Crohn's disease	2.95e-05	0.00113	CbGpPWpGaD
Cefadroxil—SLC22A8—Transmembrane transport of small molecules—ALB—Crohn's disease	2.67e-05	0.00102	CbGpPWpGaD
Cefadroxil—SLC22A6—Transmembrane transport of small molecules—ALB—Crohn's disease	2.23e-05	0.000853	CbGpPWpGaD
